Related references
Note: Only part of the references are listed.IL-8, a novel messenger to cross-link inflammation and tumor EMT via autocrine and paracrine pathways (Review)
Xinxin Long et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
Autocrine IL-8 promotes F-actin polymerization and mediate mesenchymal transition via ELMO1-NF-B-Snail signaling in glioma
Baogang Zhang et al.
CANCER BIOLOGY & THERAPY (2015)
Interleukin-8 upregulates integrin β3 expression and promotes estrogen receptor-negative breast cancer cell invasion by activating the PI3K/Akt/NF-κB pathway
Nan Shao et al.
CANCER LETTERS (2015)
Influence of functional polymorphisms in TNF-α, IL-8, and IL-10 cytokine genes on mRNA expression levels and risk of gastric cancer
Juliana Garcia de Oliveira et al.
TUMOR BIOLOGY (2015)
Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
Fanny Le Du et al.
ONCOTARGET (2015)
CECs and IL-8 have prognostic and predictive utility in patients with recurrent platinum-sensitive ovarian cancer: biomarker correlates from the randomized phase-2 trial of olaparib and cediranib compared with olaparib in recurrent platinum-sensitive ovarian cancer
Jung-Min Lee et al.
FRONTIERS IN ONCOLOGY (2015)
Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans
Archana Kamalakar et al.
BONE (2014)
A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis
Shicheng Su et al.
CANCER CELL (2014)
The depletion of Interleukin-8 causes cell cycle arrest and increases the efficacy of docetaxel in breast cancer cells
Nan Shao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Prognostic evaluation of the B cell/IL-8 metagene in different intrinsic breast cancer subtypes
Lars C. Hanker et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8
Zachary C. Hartman et al.
CANCER RESEARCH (2013)
Revealing targeted therapeutic opportunities in triple-negative breast cancers A new strategy
Graham M. Poage et al.
CELL CYCLE (2013)
A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells
Yan Zhang et al.
CELL RESEARCH (2013)
Triple-negative breast cancer: molecular characteristics and potential therapeutic approaches
Maria Nowacka-Zawisza et al.
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ (2013)
Strategies for the discovery and development of therapies for metastatic breast cancer
Bedrich L. Eckhardt et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Molecular Basis of Triple Negative Breast Cancer and Implications for Therapy
Parvin F. Peddi et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2012)
Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models
Yan Ning et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
IL-8 is a mediator of NF-kappa B induced invasion by gliomas
Baisakhi Raychaudhuri et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Deconstructing the molecular portraits of breast cancer
Aleix Prat et al.
MOLECULAR ONCOLOGY (2011)
A clinically relevant gene signature in triple negative and basal-like breast cancer
Achim Rody et al.
BREAST CANCER RESEARCH (2011)
Clinicopathological features and treatment strategy for triple-negative breast cancer
Yutaka Yamamoto et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Adjuvant Bisphosphonates in Breast Cancer: The ABCSG-12 Study
Larry J. Suva
Current Osteoporosis Reports (2010)
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
Bryan T. Hennessy et al.
CANCER RESEARCH (2009)
Adjuvant bisphosphonates in breast cancer: Are we witnessing the emergence of a new therapeutic strategy?
R. E. Coleman
EUROPEAN JOURNAL OF CANCER (2009)
Triple-Negative Breast Cancer: Risk Factors to Potential Targets
Bryan P. Schneider et al.
CLINICAL CANCER RESEARCH (2008)
How basal are triple-negative breast cancers?
Francois Bertucci et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
A potential role for interleukin-8 in the metastatic phenotype of breast carcinoma cells
JE De Larco et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
